We are live on ! Find out more
VNRX icon

VolitionRx Ltd
VNRX

25 hedge funds and large institutions have $11.2M invested in VolitionRx Ltd in 2018 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

700% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 1

39% more funds holding

Funds holding: 18 → 25 (+7)

25% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 4

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.08% less ownership

Funds ownership: 0.86% → 0.78% (-0.08%)

16% less capital invested

Capital invested by funds: $13.4M → $11.2M (-$2.17M)

Holders
25
Holders Change
+7
Holders Change %
+38.89%
% of All Funds
0.57%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
8
Increased
5
Reduced
4
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SC
Skylands Capital
Wisconsin
+$354K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$270K
3
BCM
Bridgeway Capital Management
Texas
+$263K
4
CS
Credit Suisse
Switzerland
+$190K
5
Morgan Stanley
Morgan Stanley
New York
+$119K

Top Sellers

Rank Fund Capital Flow
1
LIM
Lagoda Investment Management
New York
-$970K
2
BlackRock
BlackRock
New York
-$18.3K
3
BBHC
Brown Brothers Harriman & Co
New York
-$11K
4
UBS Group
UBS Group
Switzerland
-$9.36K
5
LCM
Leisure Capital Management
California
-$4.04K
Name Holding Trade Value Shares
Change 		Change in
Stake
LIM
1
Lagoda Investment Management
New York
$7.64M -$970K -16,588 -9%
KCM
2
Knoll Capital Management
Florida
$844K – – –
Vanguard Group
3
Vanguard Group
Pennsylvania
$714K +$270K +4,618 +45%
BCM
4
Bridgeway Capital Management
Texas
$479K +$263K +4,500 +82%
SC
5
Skylands Capital
Wisconsin
$291K +$354K +6,055 New
Morgan Stanley
6
Morgan Stanley
New York
$250K +$119K +2,040 +64%
Geode Capital Management
7
Geode Capital Management
Massachusetts
$242K – – –
LCM
8
Leisure Capital Management
California
$176K -$4.04K -69 -2%
CS
9
Credit Suisse
Switzerland
$156K +$190K +3,250 New
Northern Trust
10
Northern Trust
Illinois
$81K +$32.4K +554 +49%
Bank of New York Mellon
11
Bank of New York Mellon
New York
$40K +$18.7K +320 +62%
GBA
12
Garrison Bradford & Associates
New York
$37K – – –
Royal Bank of Canada
13
Royal Bank of Canada
Ontario, Canada
$34K – – –
Creative Planning
14
Creative Planning
Kansas
$32K – – –
SM
15
Sabby Management
Florida
$32K +$38.5K +658 New
BCM
16
BlueCrest Capital Management
Jersey
$26K +$32.2K +551 New
LTFS
17
Ladenburg Thalmann Financial Services
Florida
$25K +$30.7K +525 New
Bessemer Group
18
Bessemer Group
New Jersey
$24K – – –
AG
19
Advisor Group
Arizona
$23K – – –
RE
20
RBC Europe
United Kingdom
$15.8K – – –
BlackRock
21
BlackRock
New York
$12K -$18.3K -312 -56%
UBS Group
22
UBS Group
Switzerland
$12K -$9.36K -160 -39%
SWP
23
Stratos Wealth Partners
Ohio
$5K +$5.85K +100 New
CCA
24
Clearwater Capital Advisors
Illinois
$2K +$2.92K +50 New
TRCT
25
Tower Research Capital (TRC)
New York
$1K +$1.75K +30 New
1
2

VNRX Hedge Fund Activity: Q1 2018 in Review

25 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in VolitionRx Ltd (VNRX) for Q1 2018, worth a combined $11.2M — down 16% from $13.4M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new VNRX positions and 1 closed out — a net gain of 7 holders — while 5 added to existing stakes and 4 trimmed.

The largest buyer was Skylands Capital, opening a new position worth an estimated $354K. The largest seller was Lagoda Investment Management, cutting an estimated $970K.

  • 25 institutional investors held VolitionRx Ltd (VNRX) as of Q1 2018, up from 18 in Q4 2017.
  • Funds reported $11.2M of VolitionRx Ltd stock for Q1 2018, down 16% quarter-over-quarter.
  • 8 funds opened new VolitionRx Ltd positions in Q1 2018 and 1 closed out, a net change of +7 holders.
  • The largest VolitionRx Ltd buyer in Q1 2018 was Skylands Capital, an estimated $354K added.
  • The largest VolitionRx Ltd seller in Q1 2018 was Lagoda Investment Management, an estimated $970K sold.

Based on aggregated 13F filings for Q1 2018.